Zobrazeno 1 - 10 of 465 pro vyhledávání: '"Pilling AB"'
1
Akademický článek
Integrated analyses of multi-omic data derived from paired primary lung cancer and brain metastasis reveal the metabolic vulnerability as a novel therapeutic target.
Autor: Duan, Hao1 (AUTHOR), Ren, Jianlan2 (AUTHOR), Wei, Shiyou3 (AUTHOR), Yang, Zhenyu3 (AUTHOR), Li, Chuan3 (AUTHOR), Wang, Zhenning4 (AUTHOR), Li, Meichen5 (AUTHOR), Wei, Zhi2 (AUTHOR) zhiwei@njit.edu, Liu, Yu6 (AUTHOR), Wang, Xiuqi6 (AUTHOR), Lan, Hongbin6 (AUTHOR), Zeng, Zhen3 (AUTHOR), Xie, Maodi7 (AUTHOR), Xie, Yuan1 (AUTHOR), Wu, Suwen8 (AUTHOR), Hu, Wanming9 (AUTHOR), Guo, Chengcheng1 (AUTHOR), Zhang, Xiangheng1 (AUTHOR), Liang, Lun10 (AUTHOR), Yu, Chengwei11 (AUTHOR)
Publikováno v: Genome Medicine. 11/26/2024, Vol. 16 Issue 1, p1-30. 30p.
Zobrazit plný text záznamu
2
Akademický článek
Targeting prosurvival BCL2 signaling through Akt blockade sensitizes castration-resistant prostate cancer cells to enzalutamide.
Autor: Pilling AB; Department of Internal Medicine, Division of Hematology/Oncology, Henry Ford Health System, Henry Ford Cancer Institute, Detroit, Michigan., Hwang C; Department of Internal Medicine, Division of Hematology/Oncology, Henry Ford Health System, Henry Ford Cancer Institute, Detroit, Michigan.
Publikováno v: The Prostate [Prostate] 2019 Aug; Vol. 79 (11), pp. 1347-1359. Date of Electronic Publication: 2019 Jun 22.
Zobrazit plný text záznamu
3
Akademický článek
ALK is a critical regulator of the MYC-signaling axis in ALK positive lung cancer.
Autor: Pilling AB; University of Colorado Cancer Center, Aurora, CO, USA.; Henry Ford Cancer Institute, Detroit, MI, USA., Kim J; University of Colorado Cancer Center, Aurora, CO, USA., Estrada-Bernal A; University of Colorado Cancer Center, Aurora, CO, USA., Zhou Q; University of Colorado Cancer Center, Aurora, CO, USA., Le AT; University of Colorado Cancer Center, Aurora, CO, USA., Singleton KR; University of Colorado Cancer Center, Aurora, CO, USA., Heasley LE; University of Colorado Cancer Center, Aurora, CO, USA., Tan AC; University of Colorado Cancer Center, Aurora, CO, USA., DeGregori J; University of Colorado Cancer Center, Aurora, CO, USA., Doebele RC; University of Colorado Cancer Center, Aurora, CO, USA.
Publikováno v: Oncotarget [Oncotarget] 2018 Jan 16; Vol. 9 (10), pp. 8823-8835. Date of Electronic Publication: 2018 Jan 16 (Print Publication: 2018).
Zobrazit plný text záznamu
4
Akademický článek
Current treatment and novel insights regarding ROS1‐targeted therapy in malignant tumors.
Autor: Li, Shizhe1 (AUTHOR), Zhang, He1 (AUTHOR), Chen, Ting1 (AUTHOR), Zhang, Xiaowen2 (AUTHOR) zhangxiaowen@cmu.edu.cn, Shang, Guanning1 (AUTHOR) cmushanggn@126.com
Publikováno v: Cancer Medicine. Apr2024, Vol. 13 Issue 8, p1-17. 17p.
Zobrazit plný text záznamu
5
Akademický článek
IAP Antagonists Enhance Apoptotic Response to Enzalutamide in Castration-Resistant Prostate Cancer Cells via Autocrine TNF-α Signaling.
Autor: Pilling AB; Henry Ford Health System, Henry Ford Cancer Institute, Detroit, Michigan., Hwang O; Henry Ford Health System, Henry Ford Cancer Institute, Detroit, Michigan., Boudreault A; Pharmascience Inc. Montreal, Quebec, Canada., Laurent A; Pharmascience Inc. Montreal, Quebec, Canada., Hwang C; Henry Ford Health System, Henry Ford Cancer Institute, Detroit, Michigan.
Publikováno v: The Prostate [Prostate] 2017 Jun; Vol. 77 (8), pp. 866-877. Date of Electronic Publication: 2017 Feb 27.
Zobrazit plný text záznamu
7
Akademický článek
Dynamic monitoring of circulating tumor DNA to analyze genetic characteristics and resistance profile of lorlatinib in ALK positive previously treated NSCLC.
Autor: Ma, Xiya1 (AUTHOR), Zhang, Kun1 (AUTHOR), Xu, Jing1 (AUTHOR), Gao, Hongjun1 (AUTHOR), Yang, Shaoxing1 (AUTHOR), Qin, Haifeng1 (AUTHOR), Wang, Hong1 (AUTHOR), Gao, Fang1 (AUTHOR), Liu, Xiaoqing1 (AUTHOR) liuxiaoqing@csco.org.cn
Publikováno v: Thoracic Cancer. Jul2023, Vol. 14 Issue 20, p1980-1990. 11p.
Zobrazit plný text záznamu
8
Akademický článek
Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer.
Autor: Vaishnavi A; Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO., Capelletti M; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA., Le AT; Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO., Kako S; University of Colorado Cancer Center, Aurora, CO., Butaney M; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA., Ercan D; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA., Mahale S; University of Colorado Cancer Center, Aurora, CO., Davies KD; Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO., Aisner DL; University of Colorado Cancer Center, Aurora, CO.; Department of Pathology, University of Colorado School of Medicine, Aurora, CO., Pilling AB; Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO., Berge EM; Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO., Kim J; Department of Thoracic Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Sasaki H; Department of Oncology, Immunology and Surgery, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan., Park S; Department of Thoracic Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea., Kryukov G; Broad Institute, Cambridge, MA., Garraway LA; Broad Institute, Cambridge, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Hammerman PS; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA., Haas J; Array BioPharma, Boulder, CO., Andrews SW; Array BioPharma, Boulder, CO., Lipson D; Foundation Medicine, Inc., Boston, MA., Stephens PJ; Foundation Medicine, Inc., Boston, MA., Miller VA; Foundation Medicine, Inc., Boston, MA., Varella-Garcia M; Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO.; University of Colorado Cancer Center, Aurora, CO., Jänne PA; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA.; Belfer Institute for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA., Doebele RC; Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO.; University of Colorado Cancer Center, Aurora, CO.
Publikováno v: Nature medicine [Nat Med] 2013 Nov; Vol. 19 (11), pp. 1469-1472. Date of Electronic Publication: 2013 Oct 27.
Zobrazit plný text záznamu
9
Akademický článek
Mechanisms of resistance to crizotinib in patients with ALK gene rearranged non-small cell lung cancer.
Autor: Doebele RC; Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado 80209, USA. robert.doebele@ucdenver.edu, Pilling AB, Aisner DL, Kutateladze TG, Le AT, Weickhardt AJ, Kondo KL, Linderman DJ, Heasley LE, Franklin WA, Varella-Garcia M, Camidge DR
Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2012 Mar 01; Vol. 18 (5), pp. 1472-82. Date of Electronic Publication: 2012 Jan 10.
Zobrazit plný text záznamu
10
Akademický článek
Folate deficiency regulates expression of DNA polymerase β in response to oxidative stress.
Autor: Unnikrishnan A; Department of Nutrition and Food Science, Science College of Liberal Arts and Sciences, Wayne State University, Detroit, MI 48202, USA., Prychitko TM, Patel HV, Chowdhury ME, Pilling AB, Ventrella-Lucente LF, Papakonstantinou EV, Cabelof DC, Heydari AR
Publikováno v: Free radical biology & medicine [Free Radic Biol Med] 2011 Jan 15; Vol. 50 (2), pp. 270-80. Date of Electronic Publication: 2010 Nov 08.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje